STING can be activated by tumor DNA which produces type I IFN through the STING-IRF3 axis, or cytosolic DNA activates the cGAS-STING pathway and type I IFN production, independently of APC phagocytosis (52). This evidence concerns the gene STING1 and neoplasm.